MCID: VST001
MIFTS: 34

Vestibular Neuronitis

Categories: Ear diseases, Neuronal diseases

Aliases & Classifications for Vestibular Neuronitis

MalaCards integrated aliases for Vestibular Neuronitis:

Name: Vestibular Neuronitis 12 43 15 17 71 32
Epidemic Neurolabyrinthitis 12
Vestibular Neuritis 12

Classifications:



External Ids:

Disease Ontology 12 DOID:12683
ICD9CM 34 078.81 386.12
MeSH 43 D020338
SNOMED-CT 67 34243007 43680000
UMLS 71 C0751908

Summaries for Vestibular Neuronitis

Disease Ontology : 12 A inner ear infectious disease caused by a viral infection which involves inflammation of the vestibular nerve. It usually results as a complication of an upper respiratory infection. This causes sudden and severe vertigo, nausea and vomiting. Auditory symptoms are usually absent.

MalaCards based summary : Vestibular Neuronitis, also known as epidemic neurolabyrinthitis, is related to vestibular disease and central nervous system origin vertigo. An important gene associated with Vestibular Neuronitis is RTEL1 (Regulator Of Telomere Elongation Helicase 1). The drugs Methylprednisolone and Prednisolone acetate have been mentioned in the context of this disorder. Affiliated tissues include testes, eye and bone.

Wikipedia : 74 Labyrinthitis, also known as vestibular neuritis, is the inflammation of the inner ear. Vestibular... more...

Related Diseases for Vestibular Neuronitis

Diseases related to Vestibular Neuronitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 81)
# Related Disease Score Top Affiliating Genes
1 vestibular disease 29.9 RTEL1 OTOL1
2 central nervous system origin vertigo 29.7 CMTR2 CACNA1A
3 peripheral vertigo 29.5 RTEL1 OTOL1 CACNA1A
4 benign paroxysmal positional nystagmus 29.0 RTEL1 OTOL1 HECTD4 CMTR2 CACNA1A
5 labyrinthitis 11.9
6 viral labyrinthitis 11.7
7 neuronitis 10.8
8 pathologic nystagmus 10.5
9 dissociated nystagmus 10.2 HECTD4 FAM107B
10 spontaneous ocular nystagmus 10.2 RTEL1 CMTR2
11 migraine with or without aura 1 10.2
12 autotopagnosia 10.2 HECTD4 ASPRV1
13 developmental coordination disorder 10.2 HECTD4 ASPRV1
14 subdural empyema 10.1 SDSL ASPRV1
15 pica disease 10.0
16 panic disorder 10.0
17 hypotrichosis 1 10.0 SPIN1 FAM107B
18 branchiootic syndrome 1 10.0
19 vestibular nystagmus 10.0
20 neuritis 10.0
21 herpes simplex 10.0
22 superior semicircular canal dehiscence 10.0 SDSL RTEL1 ASPRV1
23 internuclear ophthalmoplegia 9.9 HECTD4 CACNA1A
24 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 9.9
25 carotid artery occlusion 9.9
26 herpes zoster 9.9
27 chickenpox 9.9
28 rubella 9.9
29 myoclonus and ataxia 9.9
30 rheumatoid arthritis 9.9
31 strabismus 9.9
32 vitiligo-associated multiple autoimmune disease susceptibility 6 9.9
33 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 9.9
34 homocysteinemia 9.9
35 orthostatic intolerance 9.9
36 vitiligo-associated multiple autoimmune disease susceptibility 1 9.9
37 anxiety 9.9
38 leukemia, acute lymphoblastic 3 9.9
39 cogan syndrome 9.9
40 viral meningitis 9.9
41 rickets 9.9
42 depersonalization disorder 9.9
43 somatization disorder 9.9
44 parasitic protozoa infectious disease 9.9
45 somatoform disorder 9.9
46 mechanical strabismus 9.9
47 meningitis 9.9
48 aneurysm 9.9
49 meniere disease 9.8
50 motion sickness 9.8

Graphical network of the top 20 diseases related to Vestibular Neuronitis:



Diseases related to Vestibular Neuronitis

Symptoms & Phenotypes for Vestibular Neuronitis

Drugs & Therapeutics for Vestibular Neuronitis

Drugs for Vestibular Neuronitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 37)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Methylprednisolone Approved, Vet_approved Phase 4 83-43-2 6741
2 Prednisolone acetate Approved, Vet_approved Phase 4 52-21-1
3
Methylprednisolone hemisuccinate Approved Phase 4 2921-57-5
4
Prednisolone phosphate Approved, Vet_approved Phase 4 302-25-0
5
Prednisolone Approved, Vet_approved Phase 4 50-24-8 5755
6
Betamethasone Approved, Vet_approved Phase 4 378-44-9 9782
7
Prednisolone hemisuccinate Experimental Phase 4 2920-86-7
8 Gastrointestinal Agents Phase 4
9 Antiemetics Phase 4
10 Methylprednisolone Acetate Phase 4
11 Hormone Antagonists Phase 4
12 Anti-Inflammatory Agents Phase 4
13 Antineoplastic Agents, Hormonal Phase 4
14 glucocorticoids Phase 4
15 Hormones Phase 4
16 Betamethasone benzoate Phase 4
17 Betamethasone Valerate Phase 4 2152-44-5
18 Betamethasone sodium phosphate Phase 4
19 Betamethasone-17,21-dipropionate Phase 4
20
Cilostazol Approved, Investigational Phase 3 73963-72-1 2754
21 Protective Agents Phase 3
22 Autonomic Agents Phase 3
23 Neuroprotective Agents Phase 3
24 Ginkgo Phase 3
25 Anti-Asthmatic Agents Phase 3
26 Respiratory System Agents Phase 3
27 Fibrinolytic Agents Phase 3
28 Platelet Aggregation Inhibitors Phase 3
29 Vasodilator Agents Phase 3
30 Phosphodiesterase Inhibitors Phase 3
31 Bronchodilator Agents Phase 3
32 Phosphodiesterase 3 Inhibitors Phase 3
33
Prednisone Approved, Vet_approved Phase 2 53-03-2 5865
34
Dexamethasone acetate Approved, Investigational, Vet_approved Early Phase 1 1177-87-3
35
Dexamethasone Approved, Investigational, Vet_approved Early Phase 1 50-02-2 5743
36 Kava Approved, Investigational, Nutraceutical 9000-38-8
37 BB 1101 Early Phase 1

Interventional clinical trials:

(show all 24)
# Name Status NCT ID Phase Drugs
1 Acute Unilateral Vestibulopathy and Corticosteroid Treatment Suspended NCT02912182 Phase 4 Betamethasone;Placebo;Prednisolone
2 The Efficacy of Steroid Therapy in Vestibular Neuritis Confirmed by Head Impulse Test: Prospective Randomized Controlled Study Completed NCT02098330 Phase 3 Ginkgo biloba & Methylprednisolone;Ginkgo biloba
3 A Single-center, Prospective, Randomized, Parallel Group, Placebo-controlled Exploratory Study on the Effect of Renexin Tablet in Patients With Recurrent Vestibulopathy Terminated NCT01895400 Phase 3 Renexin (cilostazol 100mg + gingko biloba extract 80 mg);Placebo
4 Prednisone Treatment for Vestibular Neuronitis Completed NCT00271791 Phase 2 Prednisone;Prednisone
5 Complementary/Alternative Medicine for Vestibulopathy Completed NCT00032383 Phase 1, Phase 2
6 INVENT VPT: Incremental Velocity Error as a New Treatment in Vestibular Rehabilitation Not yet recruiting NCT03846830 Phase 2
7 The Role of Corticosteroids and Vestibular Exercises in Recovery of Vestibular Neuritis: a Prospective Randomized Controlled Clinical Trial Unknown status NCT01231009 Early Phase 1 Corticosteroids
8 Do Migrainous Vertigo Patients Have More Hypersensitivity in Their Vestibular System Than Migraine Patients Without Vertigo? Unknown status NCT00901953
9 Clinical Utility of Simultaneous Recordings of Cervical and Ocular Vestibular-evoked Myogenic Potentials During Monaural Stimulation Unknown status NCT03049683
10 Characterisation of Cortical Vestibular Evoked Potentials (C-VEPs): A Comparative Study of Normal Ears Versus Those With Vestibular Deficits Unknown status NCT02463695
11 Comparison of Clinical and Game-based Rehabilitation for Balance Impairments and Gaze Dysfunction in Clients With Vestibular Disorders Unknown status NCT02134444
12 Positive Diagnosis of Vestibular Neuritis Using Fluid Attenuated Inversion Recuperation (FLAIR) Sequence, One Hour After Intravenous Gadolinium Injection, on a 1.5 Tesla Completed NCT03452410
13 Recovery of Visual Acuity in Vestibular Deficits Completed NCT00411216
14 Home-based Computer Gaming in Vestibular Rehabilitation: Effects on Gaze and Balance Impairment Completed NCT01943955
15 Clinical Evaluation of a Novel Balance, Vestibular and Oculomotor Assessment Tool Completed NCT02171312
16 Spatial Orientation and Vestibular Function in Patients With Acute or Chronic Unilateral Vestibular Deficits and in Patients With Bilateral Vestibular Deficits Completed NCT02212847
17 Clinical Study of Endolymphatic Sac Drainage With or Without Steroids for Intractable Meniere's Disease Completed NCT00500474
18 Which Treatment is Most Effective When Treating Vestibular Neuritis: Corticosteroid Treatment Alone or Combined Corticosteroid Treatment and Vestibular Rehabilitation? Recruiting NCT03821155 Corticosteroid
19 Production of a Device to Obtain Continuous Ambulatory Vestibular Assessment (CAVA) - Dizziness Trial Recruiting NCT04026516
20 Assessment and Treatment of Patients With Long-term Dizziness in Primary Care Recruiting NCT02655575
21 Acute Video-oculography for Vertigo in Emergency Rooms for Rapid Triage (AVERT) Recruiting NCT02483429
22 Computerized Rotational Head Impulse Test-Vertical (crHIT-vertical) Active, not recruiting NCT04087044
23 Vestibulopathy With Vestibulo Ocular Reflex (VOR) Gain Deficit - Characteristics of Overt and Covert Saccadic Eye Movements Measured by the Video Head Impulse Test (vHIT) Not yet recruiting NCT03271775
24 Validity of the French Version of the Child's Vertigo Questionnaire Not yet recruiting NCT04117620

Search NIH Clinical Center for Vestibular Neuronitis

Cochrane evidence based reviews: vestibular neuronitis

Genetic Tests for Vestibular Neuronitis

Anatomical Context for Vestibular Neuronitis

MalaCards organs/tissues related to Vestibular Neuronitis:

40
Testes, Eye, Bone, Brain, Neutrophil, T Cells, Pons

Publications for Vestibular Neuronitis

Articles related to Vestibular Neuronitis:

(show top 50) (show all 895)
# Title Authors PMID Year
1
[Objective diagnostic possibility in the differentiation of idiopathic and secondary benign paroxysmal positional vertigo]. 61
32008350 2020
2
Results in caloric test, video head impulse test and inner ear MRI in patients with Ménière's disease. 61
31272843 2020
3
Electrophysiological and inner ear MRI findings in patients with bilateral vestibulopathy. 61
32036409 2020
4
Persistent postural-perceptual dizziness: Clinical and neurophysiological study. 61
31948878 2020
5
Acute Vestibular Syndrome. 61
31994145 2020
6
Clinical Characteristics of Acute Vestibular Neuritis According to Involvement Site. 61
31789808 2020
7
Few Comments About "Clinical Course of Acute Vestibular Neuritis" Article. 61
31789809 2020
8
Efficacy of Vestibular Rehabilitation Following Acute Vestibular Neuritis: A Randomized Controlled Trial. 61
31789800 2020
9
Comparing the Suppression Head Impulse Paradigm and the Head Impulse Paradigm in Vestibular Neuritis. 61
31789804 2020
10
Dizziness demystified. 61
31326945 2019
11
Superior vestibular neuritis: improved detection using FLAIR sequence with delayed enhancement (1 h). 61
31531775 2019
12
Mean platelet volume values may not be elevated in patients with vestibular neuritis. 61
31427234 2019
13
The Evidence for Selective Loss of Otolithic Function. 61
31887751 2019
14
Examination of patients with acute dizziness in a neurological department. 61
31592615 2019
15
Benign Paroxysmal Positional Vertigo: Comparison of Idiopathic BPPV and BPPV Secondary to Vestibular Neuritis. 61
31581827 2019
16
Clinical application of cVEMPs and oVEMPs in patients affected by Ménière's disease, vestibular neuritis and benign paroxysmal positional vertigo: a systematic review. 61
31708577 2019
17
Recovery of ocular and cervical vestibular evoked myogenic potentials after treatment of inner ear diseases. 61
31070081 2019
18
The Interrelations Between Different Causes of Dizziness: A Conceptual Framework for Understanding Vestibular Disorders. 61
31018648 2019
19
Why and when to refer patients for vestibular evoked myogenic potentials: A critical review. 61
31299589 2019
20
Mean platelet volume, neutrophil- and platelet to lymphocyte ratios are elevated in vestibular neuritis. 61
31202637 2019
21
Risk of traffic accidents after onset of vestibular disease assessed with a surrogate marker. 61
30963255 2019
22
[Prevalence of peripheral vestibular diseases in children in Germany]. 61
31506769 2019
23
Analyze causes and results of VNG examinations in patients with vertigo and balance disorders in the private ENT practice. 61
32022699 2019
24
Power spectra prognostic aspects of impulsive eye movement traces in superior vestibular neuritis. 61
31055714 2019
25
[How to initially screen common central "malignant vertigo" at the bedside?] 61
31434383 2019
26
Vestibular Neurectomy for Intractable Vertigo: Case Series and Evaluation of Role of Endoscopic Assistance in Retrolabyrinthine Craniotomy. 61
31328081 2019
27
Direction-Changing and Direction-Fixed Positional Nystagmus in Patients With Vestibular Neuritis and Meniere Disease. 61
30509014 2019
28
[Evaluation of vestibular evoked myogenic potential, caloric test and cochlear electrogram in the diagnosis of Meniere's disease]. 61
31446722 2019
29
Myocardial injury in transient global amnesia: a case-control study. 61
30706590 2019
30
The Price of Immune Responses and the Role of Vitamin D in the Inner Ear. 61
31194714 2019
31
Clinical Characteristics of Acute Vestibular Neuritis According to Involvement Site. 61
30964776 2019
32
A Case of Isolated Nodular Infarction Mimicking Vestibular Neuritis on the Contralateral Side. 61
31234246 2019
33
Utricular function in vestibular neuritis: a pilot study of concordance/discordance between ocular vestibular evoked myogenic potentials and ocular cycloposition. 61
30915492 2019
34
[The clinical effects of methylprednisolone combined with vestibular rehabilitation and methylprednisolone in the treatment of vestibular neuritis]. 61
31163519 2019
35
Acute vestibular asymmetry disorder: a new disease entity in acute vestibular syndrome? 61
31035836 2019
36
Detection of intralabyrinthine abnormalities using post-contrast delayed 3D-FLAIR MRI sequences in patients with acute vestibular syndrome. 61
30413960 2019
37
Dissociation of caloric and head impulse tests: a marker of Meniere's disease. 61
31222419 2019
38
[Vertigo in children:composition and clinical characteristics]. 61
31163516 2019
39
Risk Factors for Tinnitus in 37,692 Patients Followed in General Practices in Germany. 61
30870350 2019
40
Steroids for Acute Vestibular Neuronitis-the Earlier the Treatment, the Better the Outcome? 61
30681432 2019
41
[Analysis of clinical features of secondary benign paroxysmal positional vertigo]. 61
30813689 2019
42
[The characteristics of semicircular canal injury frequency in vestibular neuritis patients]. 61
30813688 2019
43
The extent of vestibular impairment is important in recovery of canal paresis of patients with vestibular neuritis. 61
29866420 2019
44
Peripheral vestibular disorders: an update. 61
30562267 2019
45
Diagnostic value of eye movement and vestibular function tests in patients with posterior circulation infarction. 61
30767619 2019
46
Acute Dizziness. 61
30743290 2019
47
Long-term clinical outcome in vestibular neuritis. 61
30566414 2019
48
Do steroids improve recovery in vestibular neuritis? 61
30467868 2019
49
Vestibular Neuritis: Recent Advances in Etiology, Diagnostic Evaluation, and Treatment. 61
30947184 2019
50
Recovery Pattern of High-Frequency Acceleration Vestibulo-Ocular Reflex in Unilateral Vestibular Neuritis: A Preliminary Study. 61
30930826 2019

Variations for Vestibular Neuronitis

Expression for Vestibular Neuronitis

Search GEO for disease gene expression data for Vestibular Neuronitis.

Pathways for Vestibular Neuronitis

GO Terms for Vestibular Neuronitis

Sources for Vestibular Neuronitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....